These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23386922)

  • 1. Fee-for-service as a business model of growing importance: the academic biobank experience.
    McDonald SA; Sommerkamp K; Egan-Palmer M; Kharasch K; Holtschlag V
    Biopreserv Biobank; 2012 Oct; 10(5):421-5. PubMed ID: 23386922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap.
    Barnes RO; Schacter B; Kodeeswaran S; ; Watson PH
    Biopreserv Biobank; 2014 Oct; 12(5):300-5. PubMed ID: 25314324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a business model to assure financial sustainability of biobanks.
    Warth R; Perren A
    Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
    Vaught J; Rogers J; Carolin T; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical tool for modeling biospecimen user fees.
    Matzke L; Dee S; Bartlett J; Damaraju S; Graham K; Johnston R; Mes-Masson AM; Murphy L; Shepherd L; Schacter B; Watson PH
    Biopreserv Biobank; 2014 Aug; 12(4):234-9. PubMed ID: 25162459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobank and Pathology Facility: A Successful Combination.
    Alves A; Gibbon A; Carvalho S; Rodriguez-Justo M; Miranda E
    J Biomol Tech; 2022 Apr; 33(1):. PubMed ID: 35837002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing revenue through fee review and adjustment.
    Wild J; Cimerola J
    Healthc Financ Manage; 1996 Aug; 50(8):63-4. PubMed ID: 10158926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.
    Rao A; Vaught J; Tulskie B; Olson D; Odeh H; McLean J; Moore HM
    Biopreserv Biobank; 2019 Apr; 17(2):129-138. PubMed ID: 30638412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biospecimen User Fees: Global Feedback on a Calculator Tool.
    Matzke LA; Babinszky S; Slotty A; Meredith A; Castillo-Pelayo T; Henderson MK; Simeon-Dubach D; Schacter B; Watson PH
    Biopreserv Biobank; 2017 Feb; 15(1):57-64. PubMed ID: 27576065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nottingham Health Science Biobank: a sustainable bioresource.
    Matharoo-Ball B; Thomson BJ
    Biopreserv Biobank; 2014 Oct; 12(5):312-6. PubMed ID: 25340939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Business Planning in Biobanking: How to Implement a Tool for Sustainability.
    Ciaburri M; Napolitano M; Bravo E
    Biopreserv Biobank; 2017 Feb; 15(1):46-56. PubMed ID: 27898226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.